Assay of angiotensin converting enzyme in vivo
Ryan, J.W.; Berryer, P.; Chung, A.
Advances in Experimental Medicine and Biology 156: 805-812
1983
ISSN/ISBN: 0065-2598 PMID: 6305167 Document Number: 209033
Document emailed within 1 workday
Related Documents
Sakamoto, Y.; Miyazaki, T.; Kai, M.; Ohkura, Y. 1986: Sensitive assay for serum angiotensin-converting enzyme and separation of angiotensin analogues by high-performance liquid chromatography with fluorescence detection Journal of Chromatography 380(2): 313-320Roulston, J.E. 1987: Different reference intervals for the kinetic assay of angiotensin-converting enzyme Clinical Chemistry 33(12): 2324-2325
Lijnen, P.; Staessen, J.; Amery, A. 1982: Assay of plasma angiotensin-converting enzyme activity in captopril-treated subjects Methods and Findings in Experimental and Clinical Pharmacology 4(6): 413-415
Saxe, A.W.; Hollinger, M.A.; Essam, T. 1986: Effect of bilirubin on the spectrophotometric and radionuclide assay for serum angiotensin-converting enzyme Research Communications in Chemical Pathology and Pharmacology 51(1): 129-136
Oda, M.; Ino, Y.; Suzuki, K.; Sato, T.; Iwamoto, S.; Iwaki, M. 1989: Angiotensin converting enzyme inhibitory activity of MK-0521 in vivo and antihypertensive effect of its single oral administration on blood pressure and effect on the renin-angiotensin system in 2-kidney Goldblatt hypertensive dogs Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 93(4): 225-234
Kobayashi, T.; Miyauchi, T.; Sakai, S.; Yamaguchi, I.; Goto, K.; Sugishita, Y. 1998: Endothelin-converting enzyme and angiotensin-converting enzyme in failing hearts of rats with myocardial infarction Journal of Cardiovascular Pharmacology 31(Suppl): S417-S420
Gotoh, M.; Mizuno, K.; Matsui, J.; Fukuchi, S. 1983: Re-examination of measurement of spectrophotometric assay for serum angiotensin I-converting enzyme activity and its clinical evaluation in various diseases Nihon Jinzo Gakkai Shi 25(2): 121-130
Zou, K.; Michikawa, M.; Komano, H. 2010: Novel Abeta-converting activity of angiotensin-converting enzyme and its role in Alzheimer's disease Seikagaku. Journal of Japanese Biochemical Society 82(12): 1120-1124
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Aurell, M. 1984: Physiological aspects of the renin-angiotensin system and peroral angiotensin converting enzyme inhibition Scandinavian Journal of Urology and Nephrology. Supplementum 79: 9-12
Novo, S.; Adamo, L.; Giamporcaro, A.; Forte, G.; Longo, B.; Gallo, V.B.; Licata, G.; Strano, A. 1987: Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs) Agents and Actions. Supplements 22: 339-347
Haznedaroğlu, I.C. 1997: Angiotensin I-converting enzyme, blood groups, and a local marrow-specific renin-angiotensin system Experimental Hematology 25(2): 93
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Santucci, A.; Aguglia, F.; De Mattia, G.; Cammarella, I.; Trinchieri, F.; Giordano, M.; Gnecchi, M.; Ficara, C. 1983: Role of the renin-angiotensin-aldosterone system in ascitic hepatic cirrhosis. Effects of inhibition of angiotensin i converting enzyme La Clinica Terapeutica 106(2): 121-124
Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444
Kono, T.; Ikeda, F.; Oseko, F.; Imura, H.; Endo, J. 1978: Angiotensin i converting enzyme inhibitor and angiotensin Ii antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3613-3620